El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII)
Background: The economic impact of irritable bowel syndrome (IBS) in México in terms of excessive diagnostic testing can be considerably reduced if the recommendations of the Latín American Consensus (LATAM) for IBS are followed. Aim: To estímate the economic impact of IBS in terms of excessive diag...
Guardado en:
Autor principal: | |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2008
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008001100005 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872008001100005 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720080011000052009-03-23El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII)Schmulson,Max J Diagnostic tests, routine Direct service costs Irritable bowel syndrome Background: The economic impact of irritable bowel syndrome (IBS) in México in terms of excessive diagnostic testing can be considerably reduced if the recommendations of the Latín American Consensus (LATAM) for IBS are followed. Aim: To estímate the economic impact of IBS in terms of excessive diagnostic testing. Material and Methods: Based on a previously published study the costs of diagnostic testing for IBS were compared to the theoretical costs according to the recommendations of the consensus. These costs were compared to estímate the economic impact of excessive diagnostic testing. A cost-minimization analysis was also done. Results: For the lowest socioeconomic level in academic medicine, the excessive diagnostic testing had an approximate cost of US$21.38, compared to US$1.72 if the LATAM Consensus recommendations would have been followed, representing a saving of 92.0%. The cost for the highest socioeconomic level in academic medicine was US$1080.36 versus US$103.60 (a saving of 90.4%) and for prívate medicine, the costs were US$3121.60 versus US$159.90 (a saving of 94.9%) if the recommendations would have been followed. Conclusions: Limited diagnostic testing recommended by the LATAM Consensus for IBS can significantly decrease the economic impact of this disease in México.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.11 20082008-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008001100005es10.4067/S0034-98872008001100005 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Diagnostic tests, routine Direct service costs Irritable bowel syndrome |
spellingShingle |
Diagnostic tests, routine Direct service costs Irritable bowel syndrome Schmulson,Max J El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII) |
description |
Background: The economic impact of irritable bowel syndrome (IBS) in México in terms of excessive diagnostic testing can be considerably reduced if the recommendations of the Latín American Consensus (LATAM) for IBS are followed. Aim: To estímate the economic impact of IBS in terms of excessive diagnostic testing. Material and Methods: Based on a previously published study the costs of diagnostic testing for IBS were compared to the theoretical costs according to the recommendations of the consensus. These costs were compared to estímate the economic impact of excessive diagnostic testing. A cost-minimization analysis was also done. Results: For the lowest socioeconomic level in academic medicine, the excessive diagnostic testing had an approximate cost of US$21.38, compared to US$1.72 if the LATAM Consensus recommendations would have been followed, representing a saving of 92.0%. The cost for the highest socioeconomic level in academic medicine was US$1080.36 versus US$103.60 (a saving of 90.4%) and for prívate medicine, the costs were US$3121.60 versus US$159.90 (a saving of 94.9%) if the recommendations would have been followed. Conclusions: Limited diagnostic testing recommended by the LATAM Consensus for IBS can significantly decrease the economic impact of this disease in México. |
author |
Schmulson,Max J |
author_facet |
Schmulson,Max J |
author_sort |
Schmulson,Max J |
title |
El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII) |
title_short |
El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII) |
title_full |
El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII) |
title_fullStr |
El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII) |
title_full_unstemmed |
El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII) |
title_sort |
el escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (sii) |
publisher |
Sociedad Médica de Santiago |
publishDate |
2008 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008001100005 |
work_keys_str_mv |
AT schmulsonmaxj elescrutiniodiagnosticolimitadopuededisminuirelimpactoeconomicodirectodelsindromedeintestinoirritablesii |
_version_ |
1718436411585069056 |